NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

CUSIP: 44975P103

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Total 13F shares
33,200,810
Total 13F value
$132,139,164
Holder snapshot 6 visible 7 signals
Share change
+3,660,868
Put/Call ratio
182%
SEC-reported price per share
$3.98
Number of holders
57
Value change
+$14,644,437
Number of buys
35
Open additional details 1 more signal available
Number of sells
16
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
265,214,861

Security key

44975P103

Report period

Q4 2025

Institutions

57

Top holders

10

NBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 NovaBridge Biosciences SEC filings NovaBridge Biosciences company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Everest Medicines Ltd
Disclosed value leader
Everest Medicines Ltd
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 13F Lead comparable stake: 16% 13D/G row: Everest Medicines Ltd Showing 1-6 of 15 holder rows.

Quick read

Everest Medicines Ltd leads the comparable SEC ownership view at 16%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Everest Medicines Ltd's linked filing trail.
Comparable ownership Top 5
Everest Medicines Ltd 16%
JANUS HENDERSON GROUP PLC 3%
HHLR ADVISORS, LTD. 2.3%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.3%
MORGAN STANLEY 0.84%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Everest Medicines Ltd
13D/G
Everest Medicines Limited
13D/G
16%
$90,577,645
42,524,716 shares
 $0 05 Aug 2025
JANUS HENDERSON GROUP PLC
13F
Company
13F
3%
$30,287,319
7,991,377 shares
 — 30 Sep 2025
HHLR ADVISORS, LTD.
13F
Company
13F
2.3%
$22,606,547
5,980,568 shares
 — 30 Sep 2025
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
1.3%
$12,617,769
3,338,034 shares
 — 30 Sep 2025
MORGAN STANLEY
13F
Company
13F
0.84%
$8,437,112
2,232,040 shares
 — 30 Sep 2025
Ariose Capital Management Ltd
13F
Company
13F
0.64%
$6,442,606
1,704,393 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
57
Shares
33,200,810
Rows available
57
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
42
Q4 2025 holders
57
Holder diff
15
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .